Konkurencja i konsument · 15/11/1996
Nutrition 21; Selene Systems, Inc.; Herbert H. Boynton; Analysis To Aid Public Comment
In settlement of alleged violations of federal law prohibiting unfair or deceptive acts or practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would prohibit, among other things, the San Diego- based dietary supplement manufacturer and its president from making certain challenged claims for chromium picolinate dietary supplements, without competent and reliable scientific evidence to support them, and from misrepresenting the results of any test, study, or research. The settlement also requires Nutrition 21, which holds the exclusive U.S. license on the patent rights to chromium picolinate, to send its customers who resell the supplement to the public a notice of the Commission's allegations and a request to stop using sales materials making the challenged claims. The agreement settles allegations that Nutrition 21 made unsupported claims about weight loss and health benefits for chromium picolinate dietary supplements.